Sherrington Robin - 29 Dec 2023 Form 4 Insider Report for Xenon Pharmaceuticals Inc. (XENE)

Role
EVP, Strategy & Innovation
Signature
/s/ Sherry Aulin, Attorney-in-fact
Issuer symbol
XENE
Transactions as of
29 Dec 2023
Net transactions value
$0
Form type
4
Filing time
02 Jan 2024, 16:41:00 UTC
Previous filing
14 Mar 2023
Next filing
08 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XENE Common Shares Other $0 -8,398 -50% $0.000000 8,398 29 Dec 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were transferred to the Reporting Person's former spouse pursuant to the terms of a settlement agreement dated December 29, 2023 entered into in connection with the dissolution of the Reporting Person's marriage. The Reporting Person no longer reports as beneficially owned any securities owned by his former spouse.